SecBot SecBot
8-K ·Filed Nov 6, 2026

HSCS

HeartSciences Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed11d ago SEC0001213900-26-116964
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

Monitor the November 19 shareholder vote on the Fortitude merger. The supplemental disclosures address shareholder demands but do not change the vote timing or merger terms. Any further demand letters or litigation filings could signal increased risk of delay.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$2.71
T+0 close · Nov 6, 2026 · via day close
Latest settled
−23.25%
T+5 · $2.08
Vs SPY
−21.55%
α at T+5
Next horizon
T+20
in 21d
  1. T+0 · Nov 9 $2.71entry
  2. T+1 · 7d ago −11.62%α −11.26% · $2.40
  3. T+5 · yesterday −23.25%α −21.55% · $2.08
  4. T+6 · todayOpen
  5. T+20 · in 21d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

HeartSciences received seven demand letters from purported shareholders alleging the proxy statement for its merger with Fortitude Mining Holdings omits material information. The company believes the claims are without merit but voluntarily made supplemental disclosures to avoid litigation delays. The shareholder vote remains scheduled for November 19, 2026.

Key Facts

  • HeartSciences received seven demand letters from purported shareholders alleging omissions in the Preliminary Proxy Statement and/or Proxy Statement regarding the merger with Fortitude Mining Holdings.
  • The company believes the allegations are without merit and denies any further disclosure is required, but voluntarily made supplemental disclosures to avoid nuisance and possible transaction delays.
  • The special meeting of stockholders to vote on the merger remains scheduled for November 19, 2026 at 10:00 a.m. Eastern Time.
  • Fortitude's total debt was $0 and cash and cash equivalents were approximately $12.2 million as of May 31, 2026.
  • Houlihan Capital's guideline public company analysis indicated a fair value equity range for Fortitude of $206,001,900 to $428,189,900.

Financial Impact

No financial impact disclosed; supplemental disclosures are non-financial and the merger terms are unchanged.

Risk Factors

  • Potential litigation or additional shareholder demands could delay or derail the merger vote.
  • The merger is subject to shareholder approval and other closing conditions; failure to satisfy conditions could terminate the transaction.
  • Fortitude's business involves highly volatile digital assets (Zcash), which could affect the combined company's prospects.

Market Snapshot

Exchange
Nasdaq
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-116964
Document: 0001213900-26-116964-index-headers.html0001213900-26-116964
Document: 0001213900-26-116964-index.html0001213900-26-116964
Document: 0001213900-26-116964.txt0001213900-26-116964

Track record

73 reports on HSCS

Performance horizon

6 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +92.83% at T+20 after the Aug 20, 2026 report. 7 of 7 went positive at some point.

Filters
  1. Nov 17, 2026today S-3/A Bearish 5/10 Entry $2.13 Now $2.06 +3.29% settles Nov 19
  2. Nov 17, 2026today DEFA14A Neutral 5/10 Entry $2.13 Now $2.06 −3.29% settles Nov 18
  3. Nov 13, 20264d ago DEFA14A Neutral 5/10 Entry $2.08 to $2.06 Now $2.06 −0.96% ▼ −0.96% +0.05% vs SPY
  4. Nov 13, 20264d ago DEFA14A Neutral 4/10 Entry $2.13 to $2.08 Now $2.06 −3.06% ▼ −2.12% −0.21% vs SPY
  5. Nov 13, 20264d ago 8-K/A Bearish 5/10 Entry $2.13 to $2.08 Now $2.06 +3.06% ▲ +2.12% +0.21% vs SPY
  6. Nov 12, 20265d ago DEFA14A Neutral 4/10 Entry $2.26 to $2.13 Now $2.06 −8.85% ▼ −5.97% −5.61% vs SPY
  7. Nov 10, 20267d ago DEFA14A Neutral 4/10 Entry $2.30 to $2.26 Now $2.06 −10.24% ▼ −1.53% −1.17% vs SPY
  8. Nov 10, 20267d ago DEFA14A Neutral 4/10 Entry $2.40 to $2.30 Now $2.06 −13.99% ▼ −4.18% −5.49% vs SPY
  9. Nov 10, 20267d ago DEFA14A Neutral 3/10 Entry $2.40 to $2.30 Now $2.06 −13.99% ▼ −4.18% −5.49% vs SPY
  10. Nov 9, 20268d ago DEFA14A Neutral 4/10 Entry $2.40 to $2.30 Now $2.06 −13.99% ▼ −4.18% −5.49% vs SPY
Showing 10 of 73

US Market Status

Market Closed · Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026